Life Technologies Unveils First Entry in Next Generation of PCR Instruments | GenomeWeb

By Ben Butkus

Life Technologies this week introduced a new real-time PCR instrument platform that company officials said has been built from the "ground up" and is intended to serve as the template for all forthcoming platforms for the next decade.

The company introduced the platform, called the ViiA 7 real-time PCR system, at an event held Sunday as part of the American Association for Cancer Research annual meeting in Washington, DC.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.